Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Norwegian (OSEAX) Pharma Industry Analysis

UpdatedApr 22, 2026
DataAggregated Company Financials
Companies5
  • 7D-1.6%
  • 3M2.3%
  • 1Y14.8%
  • YTDn/a

The Pharma industry is up 6.6% in the last week, with Navamedic up 10%. In the last 12 months, the industry was up 21%. Earnings are forecast to grow by 53% annually.

Industry Valuation and Performance

Has the Norwegian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 22 Apr 2026NOK 3.8bNOK 1.6b-NOK 67,842,000.0013.6x-55.8x2.4x
Fri, 20 Mar 2026NOK 3.5bNOK 1.6b-NOK 60,027,434.0012.9x-58.7x2.2x
Sun, 15 Feb 2026NOK 3.5bNOK 1.6b-NOK 56,390,434.00402x-61.6x2.2x
Tue, 13 Jan 2026NOK 3.9bNOK 1.6b-NOK 67,438,434.00492.1x-57.7x2.5x
Thu, 11 Dec 2025NOK 3.7bNOK 1.6b-NOK 67,438,434.00423.5x-54.2x2.3x
Sat, 08 Nov 2025NOK 3.3bNOK 1.6b-NOK 79,791,434.00366.3x-41.3x2.1x
Mon, 06 Oct 2025NOK 3.3bNOK 1.5b-NOK 83,687,434.0013.4x-39.1x2.1x
Wed, 03 Sep 2025NOK 3.4bNOK 1.5b-NOK 87,981,434.0013.6x-39x2.2x
Fri, 01 Aug 2025NOK 3.6bNOK 1.5b-NOK 99,333,434.0014.1x-36.2x2.4x
Sun, 29 Jun 2025NOK 3.3bNOK 1.5b-NOK 91,864,434.00343.8x-36.2x2.2x
Tue, 27 May 2025NOK 3.2bNOK 1.5b-NOK 122,678,000.00322.7x-26.2x2.1x
Thu, 24 Apr 2025NOK 3.2bNOK 1.5b-NOK 129,957,000.00150.9x-24.8x2.1x
Sat, 22 Mar 2025NOK 3.3bNOK 1.5b-NOK 153,695,743.00158.7x-21.7x2.2x
Mon, 17 Feb 2025NOK 3.3bNOK 1.5bNOK 5.5m109x593.3x2.2x
Wed, 15 Jan 2025NOK 3.0bNOK 1.5bNOK 22.4m22.2x134.5x2x
Fri, 13 Dec 2024NOK 3.1bNOK 1.5bNOK 22.4m22.7x137.6x2.1x
Sun, 10 Nov 2024NOK 3.0bNOK 1.5bNOK 33.3m21.8x91.5x2.1x
Tue, 08 Oct 2024NOK 3.2bNOK 1.5bNOK 45.2m22.7x71x2.1x
Thu, 05 Sep 2024NOK 3.0bNOK 1.5bNOK 105.8m20x28.1x2x
Sat, 03 Aug 2024NOK 2.9bNOK 1.5bNOK 49.7m153.4x58x2x
Mon, 01 Jul 2024NOK 3.2bNOK 1.5bNOK 49.7m174.9x63.5x2.2x
Wed, 29 May 2024NOK 3.3bNOK 1.5bNOK 7.6m187.8x442.1x2.3x
Fri, 26 Apr 2024NOK 3.2bNOK 1.5bNOK 18.3m155.9x176x2.2x
Sun, 24 Mar 2024NOK 3.2bNOK 1.5bNOK 33.1m162.3x95.6x2.2x
Tue, 20 Feb 2024NOK 3.3bNOK 1.4b-NOK 826,125.0096.9x-4045.7x2.3x
Thu, 18 Jan 2024NOK 3.5bNOK 1.4bNOK 18.6m25.2x188.5x2.5x
Sat, 16 Dec 2023NOK 3.6bNOK 1.4bNOK 18.6m25.2x191.8x2.5x
Mon, 13 Nov 2023NOK 3.1bNOK 1.4bNOK 18.6m24.5x167.8x2.2x
Wed, 11 Oct 2023NOK 3.2bNOK 1.3b-NOK 38,433,125.0052.2x-83.5x2.4x
Fri, 08 Sep 2023NOK 2.8bNOK 1.3b-NOK 53,836,125.0048.4x-52.7x2.1x
Sun, 06 Aug 2023NOK 3.0bNOK 1.2b-NOK 60,357,125.0076.7x-50.2x2.4x
Tue, 04 Jul 2023NOK 3.0bNOK 1.2b-NOK 60,357,125.0072.6x-49.6x2.4x
Thu, 01 Jun 2023NOK 3.2bNOK 1.2b-NOK 104,503,000.0080.1x-30.2x2.6x
Sat, 29 Apr 2023NOK 3.1bNOK 1.1b-NOK 140,813,000.0021.3x-22.1x2.9x
Price to Earnings Ratio

-22.1x


Total Market Cap: NOK 3.1bTotal Earnings: -NOK 140,813,000.00Total Revenue: NOK 1.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Pharma Industry Price to Earnings3Y Average 37.8x202420252026
Current Industry PE
  • Investors are optimistic on the Norwegian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 2.2x is lower than the industry's current PS ratio of 2.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 13% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Norwegian Pharma compare with similar industries?

NO Market-2.36%
Healthcare0.43%
Pharma-1.55%
Pharma-1.55%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NAVA NavamedicNOK 21.609.6%
+NOK 45.6m		3.8%PS0.9x
VISTN Vistin PharmaNOK 22.800.9%
+NOK 8.9m		-5.0%PE13.5x

Latest News

NAVA
NOK 21.60
Navamedic
7D
9.6%
1Y
3.8%
PHO
NOK 69.50
Photocure
7D
-3.6%
1Y
27.8%
SOFTX
NOK 0.11
SoftOx Solutions
7D
-15.4%
1Y
77.7%

We Think SoftOx Solutions (OB:SOFTX) Needs To Drive Business Growth Carefully

Mar 28
We Think SoftOx Solutions (OB:SOFTX) Needs To Drive Business Growth Carefully
ONCIN
NOK 49.50
Oncoinvent
7D
-1.0%
1Y
n/a
VISTN
NOK 22.80
Vistin Pharma
7D
0.9%
1Y
-5.0%